S-1 in combination with CPT-11 plus trastuzumab for pretreated HER2+metastatic breast cancer

被引：0
|
作者：
Toh, U. [1 ]
Iwakuma, N. [1 ]
Mishima, M. [1 ]
Furukawa, M. [1 ]
Fujii, T. [1 ]
Ogo, E. [2 ]
Nakagawa, S. [3 ]
Tanaka, M. [4 ]
Akagi, Y. [1 ]
机构：
[1] Kurume Univ, Sch Med, Surg, Kurume, Fukuoka 830, Japan
[2] Kurume Univ, Sch Med, Radiol, Kurume, Fukuoka 830, Japan
[3] Natl Hosp Org, Kyushu Med Ctr, Breast Surg, Fukuoka, Japan
[4] Kurume Gen Hosp, Breast Surg, Kurume, Fukuoka, Japan
来源：
BREAST | 2015年 / 24卷
关键词：
D O I：
10.1016/S0960-9776(15)70059-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P008
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [31] Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 in patients with advanced gastric cancer refractory to S-1 or S-1 plus CDDP.
    Kawase, Tomono
    Imamura, Hiroshi
    Gotoh, Masahiro
    Kimura, Yutaka
    Ueda, Shugo
    Matsuyama, Jin
    Nishikawa, Kazuhiro
    Sugimoto, Naotoshi
    Fujita, Junya
    Tamura, Takao
    Fukushima, Norimasa
    Kawabata, Ryohei
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Sakai, Daisuke
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] COST-EFFECTIVENESS ANALYSIS OF TRASTUZUMAB DERUXTECAN FOR PATIENTS WITH HER2+METASTATIC BREAST CANCER
    Mudumba, R.
    Chan, H.
    Cheng, Y. Y.
    Wang, C. C.
    Correia, L.
    Ballreich, J.
    Levy, J.
    VALUE IN HEALTH, 2022, 25 (12) : S95 - S95
  • [33] Phase II study of S-1 in combination with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer (KSCOG-BC01)
    Toh, U.
    Fukushima, T.
    Fukunaga, M.
    Iwakuma, N.
    Takenaka, M.
    Otsuka, H.
    Shirouzu, K.
    Ogo, E.
    EJC SUPPLEMENTS, 2010, 8 (03): : 204 - 204
  • [34] Successful treatment with S-1 plus CPT-11 for lymph node metastasis from colon cancer: Report of a case
    Yoshimatsu, Kazuhiko
    Fujimoto, Hajime Yokomizo Takashi
    Otani, Taisuke
    Matsumoto, Atsuo
    Osawa, Gakuji
    Itagaki, Hiroko
    Umehara, Arihiri
    Shiozawa, Shunichi
    Katsube, Takao
    Naritaka, Yoshihiko
    Ogawa, Kenji
    ANTICANCER RESEARCH, 2008, 28 (1B) : 559 - 562
  • [35] Trastuzumab emtansine, an antibody-drug conjugate for the treatment of HER2+metastatic breast cancer
    Niculescu-Duvaz, Ion
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (03) : 350 - 360
  • [36] Trastuzumab and vinorelbine or taxane chemotherapy for HER2+metastatic breast cancer: The TRAVIOTA study.
    Burstein, H. J.
    Keshaviah, A.
    Baron, A.
    Hart, R.
    Lambert-Falls, R.
    Marcom, P. K.
    Gelman, R.
    Winer, E. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 40S - 40S
  • [37] A Phase II Study of Combined Chemotherapy with 5-Week Cycles of S-1 and CPT-11 plus Bevacizumab in Patients with Metastatic Colon Cancer
    Mizushima, Tsunekazu
    Ide, Yoshito
    Murata, Kohei
    Ohashi, Ichiro
    Yasumasa, Keigo
    Fukunaga, Mutsumi
    Takemoto, Hiroyoshi
    Tamagawa, Hiroshi
    Hasegawa, Junichi
    Hata, Taishi
    Takemasa, Ichiro
    Ikeda, Masataka
    Yamamoto, Hirofumi
    Sekinnoto, Mitsugu
    Nezu, Riichiro
    Doki, Yuichiro
    Mori, Masaki
    ONCOLOGY, 2013, 85 (06) : 317 - 322
  • [38] COST-EFFECTIVENESS ANALYSIS OF TRASTUZUMAB plus DOCETAXEL VERSUS DOCETAXEL ALONE IN THE TREATMENT OF HER2+METASTATIC BREAST CANCER
    Athanasakis, K.
    Golna, C.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2011, 14 (07) : A449 - A449
  • [39] Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer
    Osako, Tomo
    Ito, Yoshinori
    Takahashi, Shunji
    Tokudome, Nahomi
    Iwase, Takuji
    Hatake, Kiyohiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 159 - 164
  • [40] Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer
    Tomo Osako
    Yoshinori Ito
    Shunji Takahashi
    Nahomi Tokudome
    Takuji Iwase
    Kiyohiko Hatake
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 159 - 164
12345